Of Peritoneal Dialysis Access and Home Dialysis Accessibility
- PMID: 38170600
- PMCID: PMC10786605
- DOI: 10.1681/ASN.0000000000000276
Of Peritoneal Dialysis Access and Home Dialysis Accessibility
Conflict of interest statement
J. Perl reports Consultancy: AstraZeneca, Baxter Health Care Canada, Bayer, Davita Healthcare Partners, Fresenius Medical Care, LiberDi, Otsuka, and Outset Medical; Ownership Interest: I-Ren; Research Funding: AHRQ and Arbor Research Collaborative For Health; Honoraria: AstraZeneca, Baxter Healthcare USA/Canada, Bayer Canada, Davita Healthcare partners, DCI, Fresenius Medical Care, Innovative Renal Care, United StatesOtsuka, and US Renal Care; Speakers Bureau: Baxter Healthcare and Fresenius Medical Care; and Other Interests or Relationships: Salary Support: AHRQ and Arbor Research Collaborative For Health. I. Teitelbaum reports Consultancy: Triomed; Ownership Interest: i-RenMedical; Advisory or Leadership Role: Associate Editor of
Comment on
-
Peritoneal Dialysis Catheter Complications after Insertion by Surgeons, Radiologists, or Nephrologists.J Am Soc Nephrol. 2024 Jan 1;35(1):85-93. doi: 10.1681/ASN.0000000000000250. Epub 2023 Oct 17. J Am Soc Nephrol. 2024. PMID: 37846202 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
